HMGB1 gene polymorphism is associated with hypertension in Han Chinese population

References

• He J, Gu D, Wu X, et al. Major causes of death among men and women in China. N Engl J Med 2005;353:1124–34
   PubMed Web of Science ®Google Scholar
• Kannel WB, Schwartz MJ, McNamara PM. Blood pressure and risk of coronary heart disease: the Framingham study. Dis Chest 1969;56:43–52
   PubMedGoogle Scholar
• Staessen JA, Wang J, Bianchi G, et al. Essential hypertension. Lancet 2003;361:1629–41
   PubMed Web of Science ®Google Scholar
• Ross R. Atherosclerosis – an inflammatory disease. N Engl J Med 1999;340:115–26
   PubMed Web of Science ®Google Scholar
• Fiuza C, Bustin M, Talwar S, et al. Inflammation-promoting activity of HMGB1 on human microvascular endothelial cells. Blood 2003;101:2652–60
   PubMed Web of Science ®Google Scholar
• Treutiger CJ, Mullins GE, Johansson AS, et al. High mobility group 1 B-box mediates activation of human endothelium. J Intern Med 2003;254:375–85
   PubMed Web of Science ®Google Scholar
• Schmidt AM, Yan SD, Yan SF, Stern DM. The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses. J Clin Invest 2001;108:949–55
   PubMed Web of Science ®Google Scholar
• Yan SF, Ramasamy R, Schmidt AM. Receptor for AGE (RAGE) and its ligands-cast into leading roles in diabetes and the inflammatory response. J Mol Med (Berl) 2009;87:235–47
   PubMed Web of Science ®Google Scholar
• Yao D, Brownlee M. Hyperglycemia-induced reactive oxygen species increase expression of the receptor for advanced glycation end products (RAGE) and RAGE ligands. Diabetes 2010;59:249–55
   PubMed Web of Science ®Google Scholar
• Zhao Y, Wang H, Liu S, et al. Association study of CRP gene polymorphism and hypertension in Han Chinese population. Gene 2013;512:41–6
   PubMed Web of Science ®Google Scholar
• Foell D, Wittkowski H, Roth J. Mechanisms of disease: a ‘DAMP’ view of inflammatory arthritis. Nat Clin Pract Rheumatol 2007;3:382–90
   PubMedGoogle Scholar
• Rubartelli A, Lotze MT. Inside, outside, upside down: damage-associated molecular-pattern molecules (DAMPs) and redox. Trends Immunol 2007;28:429–36
   PubMed Web of Science ®Google Scholar
• Bianchi ME. DAMPs, PAMPs and alarmins: all we need to know about danger. J Leukoc Biol 2007;81:1–5
   PubMed Web of Science ®Google Scholar
• Read CM, Cary PD, Crane-Robinson C, et al. Solution structure of a DNA-binding domain from HMG1. Nucleic Acids Res 1993;21:3427–36
   PubMed Web of Science ®Google Scholar
• Javaherian K, Liu JF, Wang JC. Nonhistone proteins HMG1 and HMG2 change the DNA helical structure. Science 1978;199:1345–6
   PubMed Web of Science ®Google Scholar
• Wang H, Bloom O, Zhang M, et al. HMG-1 as a late mediator of endotoxin lethality in mice. Science 1999;285:248–51
   PubMed Web of Science ®Google Scholar
• Lu B, Nakamura T, Inouye K, et al. Novel role of PKR in inflammasome activation and HMGB1 release. Nature 2012;488:670–4
   PubMed Web of Science ®Google Scholar
• Park JS, Svetkauskaite D, He Q, et al. Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein. J Biol Chem 2004;279:7370–7
   PubMed Web of Science ®Google Scholar
• Hori O, Brett J, Slattery T, et al. The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. Mediation of neurite outgrowth and co-expression of rage and amphoterin in the developing nervous system. J Biol Chem 1995;270:25752–61
   PubMed Web of Science ®Google Scholar
• Yan XX, Lu L, Peng WH, et al. Increased serum HMGB1 level is associated with coronary artery disease in nondiabetic and type 2 diabetic patients. Atherosclerosis 2009;205:544–8
   PubMed Web of Science ®Google Scholar
• Yang D, Chen Q, Yang H, et al. High mobility group box-1 protein induces the migration and activation of human dendritic cells and acts as an alarmin. J Leukoc Biol 2007;81:59–66
   PubMed Web of Science ®Google Scholar
• Hreggvidsdottir HS, Lundberg AM, Aveberger AC, et al. High mobility group box protein 1 (HMGB1)-partner molecule complexes enhance cytokine production by signaling through the partner molecule receptor. Mol Med 2012;18:224–30
   PubMed Web of Science ®Google Scholar
• de Souza AW, Westra J, Limburg PC, et al. HMGB1 in vascular diseases: its role in vascular inflammation and atherosclerosis. Autoimmun Rev 2012;11:909–17
   PubMed Web of Science ®Google Scholar
• Xu H, Yao Y, Su Z, et al. Endogenous HMGB1 contributes to ischemia-reperfusion-induced myocardial apoptosis by potentiating the effect of TNF-α/JNK. Am J Physiol Heart Circ Physiol 2011;300:H913–21
   PubMed Web of Science ®Google Scholar
• Andrassy M, Volz HC, Igwe JC, et al. High-mobility group box-1 in ischemia-reperfusion injury of the heart. Circulation 2008;117:3216–26
   PubMed Web of Science ®Google Scholar
• Kitahara T, Takeishi Y, Harada M, et al. High-mobility group box 1 restores cardiac function after myocardial infarction in transgenic mice. Cardiovasc Res 2008;80:40–6
   PubMed Web of Science ®Google Scholar
• Limana F, Germani A, Zacheo A, et al. Exogenous high-mobility group box 1 protein induces myocardial regeneration after infarction via enhanced cardiac C-kit + cell proliferation and differentiation. Circ Res 2005;97:e73–83
   PubMed Web of Science ®Google Scholar
• Takahashi K, Fukushima S, Yamahara K, et al. Modulated inflammation by injection of high-mobility group box 1 recovers post-infarction chronically failing heart. Circulation 2008;118:S106–14
   PubMed Web of Science ®Google Scholar
• Limana F, Esposito G, D’Arcangelo D, et al. HMGB1 attenuates cardiac remodelling in the failing heart via enhanced cardiac regeneration and miR-206-mediated inhibition of TIMP-3. PLoS One 2011;6:e19845
   PubMed Web of Science ®Google Scholar
• Bauer EM, Shapiro R, Zheng H, et al. High mobility group box 1 contributes to the pathogenesis of experimental pulmonary hypertension via activation of Toll-like receptor 4. Mol Med 2012;18:1509–18
   Web of Science ®Google Scholar
• Guo SW, Thompson EA. Performing the exact test of Hardy-Weinberg proportion for multiple alleles. Biometrics 1992;48:361–72
   PubMed Web of Science ®Google Scholar
• Zeng L, Zhang AQ, Gu W, et al. Clinical relevance of single nucleotide polymorphisms of the high mobility group box 1 protein gene in patients with major trauma in southwest China. Surgery 2012;151:427–36
   PubMed Web of Science ®Google Scholar
• Kornblit B, Masmas T, Petersen SL, et al. Association of HMGB1 polymorphisms with outcome after allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant 2010;16:239–52
   PubMed Web of Science ®Google Scholar
• Lunetta KL, D’Agostino RB Sr, Karasik D, et al. Genetic correlates of longevity and selected age-related phenotypes: a genome-wide association study in the Framingham Study. BMC Med Genet 2007;8:S13
   PubMed Web of Science ®Google Scholar
• Shen C, Lu X, Li Y, et al. Emilin1 gene and essential hypertension: a two-stage association study in northern Han Chinese population. BMC Med Genet 2009;10:118
   PubMed Web of Science ®Google Scholar
• Lasky-Su J, Lyon HN, Emilsson V, et al. On the replication of genetic associations: timing can be everything! Am J Hum Genet 2008;82:849–58
   PubMed Web of Science ®Google Scholar
• Percy CJ, Brown L, Power DA, et al. Obesity and hypertension have differing oxidant handling molecular pathways in age-related chronic kidney disease. Mech Ageing Dev 2009;130:129–38
   PubMed Web of Science ®Google Scholar
• Darne B, Girerd X, Safar M, et al. Pulsatile versus steady component of blood pressure: a cross-sectional analysis and a prospective analysis on cardiovascular mortality. Hypertension 1989;13:392–400
   PubMed Web of Science ®Google Scholar
• Bostom AG, Cupples LA, Jenner JL, et al. Elevated plasma lipoprotein(a) and coronary heart disease in men aged 55 years and younger. A prospective study. J Am Med Assoc 1996;276:544–8
   PubMed Web of Science ®Google Scholar
• Kannel WB, Hjortland MC, McNamara PM, Gordon T. Menopause and risk of cardiovascular disease: the Framingham study. Ann Intern Med 1976;85:447–52
   PubMed Web of Science ®Google Scholar
• Berry JD, Dyer A, Cai X, et al. Lifetime risks of cardiovascular disease. N Engl J Med 2012;366:321–9
   PubMed Web of Science ®Google Scholar
• Yang S, Wang H, Yang Y, et al. Association study of AGER gene polymorphism and hypertension in Han Chinese population. Gene 2012;498:311–16
   PubMed Web of Science ®Google Scholar